217 related articles for article (PubMed ID: 8038494)
1. Treatment of chronic lymphocytic leukaemia. French Co-operative Group on CLL.
Binet JL
Baillieres Clin Haematol; 1993 Dec; 6(4):867-78. PubMed ID: 8038494
[TBL] [Abstract][Full Text] [Related]
2. Management of chronic lymphocytic leukemia.
Han T; Rai KR
Hematol Oncol Clin North Am; 1990 Apr; 4(2):431-45. PubMed ID: 2182600
[TBL] [Abstract][Full Text] [Related]
3. A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia.
Kimby E; Brandt L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):224-30. PubMed ID: 11441934
[TBL] [Abstract][Full Text] [Related]
4. Achieving optimal outcomes in chronic lymphocytic leukaemia.
Hamblin TJ
Drugs; 2001; 61(5):593-611. PubMed ID: 11368285
[TBL] [Abstract][Full Text] [Related]
5. Therapy program for patients with advanced stages of chronic lymphocytic leukemia. Chlorambucil, splenectomy, and total lymph node irradiation.
Pegourie-Bandelier B; Sotto JJ; Hollard D; Bolla M; Sarrazin R
Cancer; 1995 Jun; 75(12):2853-61. PubMed ID: 7773934
[TBL] [Abstract][Full Text] [Related]
6. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
Johnson S; Smith AG; Löffler H; Osby E; Juliusson G; Emmerich B; Wyld PJ; Hiddemann W
Lancet; 1996 May; 347(9013):1432-8. PubMed ID: 8676625
[TBL] [Abstract][Full Text] [Related]
7. Management of chronic lymphocytic leukaemia.
Kalil N; Cheson BD
Drugs Aging; 2000 Jan; 16(1):9-27. PubMed ID: 10733261
[TBL] [Abstract][Full Text] [Related]
8. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
9. First-line therapy of advanced chronic lymphocytic leukemia.
Wilhelm M; Tony HP; Rueckle-Lanz H; Wilms K
Leukemia; 1997 Apr; 11 Suppl 2():S14-8. PubMed ID: 9178832
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
[TBL] [Abstract][Full Text] [Related]
11. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists' Collaborative Group.
J Natl Cancer Inst; 1999 May; 91(10):861-8. PubMed ID: 10340906
[TBL] [Abstract][Full Text] [Related]
13. Chlorambucil plus theophylline vs chlorambucil alone as a front line therapy for B-cell chronic lymphatic leukemia.
Mabed M; Aref S; Fouda M; El-Sharawy S
Leuk Lymphoma; 2004 Oct; 45(10):2029-35. PubMed ID: 15370247
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukaemia treatment.
Montserrat E; Rozman C
Blood Rev; 1993 Sep; 7(3):164-75. PubMed ID: 8241831
[TBL] [Abstract][Full Text] [Related]
15. Current approaches to the treatment and management of chronic lymphocytic leukaemia.
Montserrat E; Rozman C
Drugs; 1994; 47 Suppl 6():1-9. PubMed ID: 7525184
[TBL] [Abstract][Full Text] [Related]
16. The UK Medical Research Council CLL trials 1 and 2.
Catovsky D; Fooks J; Richards S
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):423-7. PubMed ID: 3222154
[TBL] [Abstract][Full Text] [Related]
17. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
18. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
Dighiero G; Maloum K; Desablens B; Cazin B; Navarro M; Leblay R; Leporrier M; Jaubert J; Lepeu G; Dreyfus B; Binet JL; Travade P
N Engl J Med; 1998 May; 338(21):1506-14. PubMed ID: 9593789
[TBL] [Abstract][Full Text] [Related]
19. New modalities of therapy in chronic lymphocytic leukemia.
Cheson BD
Crit Rev Oncol Hematol; 1991 Sep; 11(3):167-77. PubMed ID: 1958310
[TBL] [Abstract][Full Text] [Related]
20. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Thieblemont C; Felman P; Berger F; Dumontet C; Arnaud P; Hequet O; Arcache J; Callet-Bauchu E; Salles G; Coiffier B
Clin Lymphoma; 2002 Jun; 3(1):41-7. PubMed ID: 12141954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]